CLINICAL_TRIALS ClinicalTrials.gov record update

The Durability of Protection Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Women Aged 18 to 45 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04969445
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:50.008893+00:00
Published At: 2023-01-26T00:00:00+00:00
Record Updated At: 2023-01-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cervical Intraepithelial Neoplasia", "Cervical Cancer", "Vaginal Intraepithelial Neoplasia", "Vulvar Intraepithelial Neoplasia", "Persistent Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-01-26"
protocolSection.identificationModule.nctId: "NCT04969445"
protocolSection.identificationModule.officialTitle: "The Durability of Protection Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Women Aged 18 to 45 Years"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.